US Patent 10421804 Anti-Zika virus antibodies and methods of use
Patent 10421804 was granted and assigned to Regeneron Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 17, 2017
Date of Patent
September 24, 2019
Patent Applicant
Patent Application Number
15651387
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10421804 Anti-Zika virus antibodies and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
